Latest Deep brain stimulation Stories
LOS ANGELES, April 25, 2011 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles-based medical device company, today announced research progress on three therapies employing trigeminal nerve stimulation (TNS), originally developed at UCLA and exclusively licensed to NeuroSigma.
Deep brain stimulation, a surgical procedure to suppress faulty nerve signals, allowed 77 percent of patients to stop the medications used to treat their essential tremors within one year following the surgery, University of South Florida researchers report.
LOS ANGELES, April 4, 2011 /PRNewswire/ -- NeuroSigma, Inc.
The first two stereo-EEG explorations in Finland were carried out by neurosurgeons of the Epilepsy surgery team in Helsinki University Central Hospital this spring.
A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery.
A gene therapy called NLX-P101 dramatically reduces movement impairment in Parkinson's patients.
DETROIT, March 16, 2011 /PRNewswire/ -- A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery. "The study demonstrates that the promise of gene therapy for neurodegenerative disorders has become a reality," says study lead author and co-principal investigator Peter LeWitt, M.D., director of movement disorders at...
FORT LEE, N.J., March 16, 2011 /PRNewswire/ -- Neurologix, Inc.
A new study sheds light--both literally and figuratively--on the intricate brain cell connections responsible for anxiety.
Movement disorders such as Parkinson's diseases and dystonia are caused by abnormal neural activity of the basal ganglia located deep in the brain.
- Emitting flashes of light; glittering.
More Images (1 images) »